167 related articles for article (PubMed ID: 329858)
41. Suppression of prolactin secretion during ovarian hyperstimulation is followed by elevated serum levels of endometrial protein PP14 in the late luteal phase.
Seppälä M; Martikainen H; Rönnberg L; Riittinen L; Kauppila A
Hum Reprod; 1989 May; 4(4):389-91. PubMed ID: 2745669
[TBL] [Abstract][Full Text] [Related]
42. Bromocriptine in polycystic ovarian disease: a controlled clinical trial.
el Tabbakh GH; Loutfi IA; Azab I; Rahman HA; Southren AL; Aleem FA
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):301-6. PubMed ID: 3279350
[TBL] [Abstract][Full Text] [Related]
43. [Premenstrual syndrome and bromocriptine].
Tolino A; Cardone A; De Conciliis B; Mastrantonio P
Riv Ital Ginecol; 1977; 58(5):379-83. PubMed ID: 576043
[No Abstract] [Full Text] [Related]
44. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome.
Baker ER; Best RG; Manfredi RL; Demers LM; Wolf GC
J Assist Reprod Genet; 1995 Mar; 12(3):205-9. PubMed ID: 8520187
[TBL] [Abstract][Full Text] [Related]
45. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
Seppälä M; Unnérus HA; Hirvonen E; Ranta T
J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
[TBL] [Abstract][Full Text] [Related]
46. Effect of bromocriptine on menstrual cycle length.
Smith SK; Sobowale O; Lenton EA; Cooke ID
Br J Obstet Gynaecol; 1984 Mar; 91(3):251-5. PubMed ID: 6422976
[TBL] [Abstract][Full Text] [Related]
47. Isolating with physical restraint low status female monkeys during luteal phase might make an appropriate premenstrual depression syndrome model.
Qiao M; Zhao Q; Zhang H; Wang H; Xue L; Wei S
J Affect Disord; 2007 Sep; 102(1-3):81-91. PubMed ID: 17258814
[TBL] [Abstract][Full Text] [Related]
48. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. progesterone Study Group.
Magill PJ
Br J Gen Pract; 1995 Nov; 45(400):589-93. PubMed ID: 8554838
[TBL] [Abstract][Full Text] [Related]
49. Essential fatty acids for premenstrual syndrome and their effect on prolactin and total cholesterol levels: a randomized, double blind, placebo-controlled study.
Rocha Filho EA; Lima JC; Pinho Neto JS; Montarroyos U
Reprod Health; 2011 Jan; 8():2. PubMed ID: 21241460
[TBL] [Abstract][Full Text] [Related]
50. Prolactin levels and bromocriptine treatment of short luteal phase.
Lehtovirta P; Arjomaa P; Ranta T; Laatikainen T; Hirvonen E; Seppälä M
Int J Fertil; 1979; 24(1):57-60. PubMed ID: 37181
[TBL] [Abstract][Full Text] [Related]
51. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study.
LeWitt PA; Gopinathan G; Ward CD; Sanes JN; Dambrosia JM; Durso R; Calne DB
Neurology; 1982 Jan; 32(1):69-72. PubMed ID: 7033825
[TBL] [Abstract][Full Text] [Related]
52. Bromocriptine for severe mastalgia.
Mansel RE; Preece PE; Hughes LE
Br Med J; 1977 May; 1(6072):1356. PubMed ID: 577188
[No Abstract] [Full Text] [Related]
53. Progesterone and the premenstrual syndrome: a double blind crossover trial.
Dennerstein L; Spencer-Gardner C; Gotts G; Brown JB; Smith MA; Burrows GD
Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1617-21. PubMed ID: 3924191
[TBL] [Abstract][Full Text] [Related]
54. Prolactin suppression by bromocriptine stimulates aromatization of testosterone to estradiol in women.
Martikainen H; Rönnberg L; Puistola U; Tapanainen J; Orava M; Kauppila A
Fertil Steril; 1989 Jul; 52(1):51-4. PubMed ID: 2744187
[TBL] [Abstract][Full Text] [Related]
55. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study. II. Endocrine correlates.
London RS; Sundaram G; Manimekalai S; Murphy L; Reynolds M; Goldstein P
J Am Coll Nutr; 1984; 3(4):351-6. PubMed ID: 6238991
[TBL] [Abstract][Full Text] [Related]
56. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
Rea N; Bove F; Gentile A; Parmeggiani U
Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
[TBL] [Abstract][Full Text] [Related]
57. Role of bromocriptine and pyridoxine in premenstrual tension syndrome.
Sharma P; Kulshreshtha S; Singh GM; Bhagoliwal A
Indian J Physiol Pharmacol; 2007; 51(4):368-74. PubMed ID: 18476391
[TBL] [Abstract][Full Text] [Related]
58. Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinemic patients.
Bennink HJ
Fertil Steril; 1979 Mar; 31(3):267-72. PubMed ID: 571359
[TBL] [Abstract][Full Text] [Related]
59. A double blind trial of the prolactin inhibitor bromocriptine in painful benign breast disease.
Mansel RE; Preece PE; Hughes LE
Br J Surg; 1978 Oct; 65(10):724-7. PubMed ID: 361149
[TBL] [Abstract][Full Text] [Related]
60. Prolactin changes in maternal plasma following termination by vacuum curettage and the effect of bromocriptine treatment on these changes.
Ylikorkala O; Rönnberg L
Br J Obstet Gynaecol; 1980 Oct; 87(10):911-5. PubMed ID: 7426491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
